Faculty

Institution

Unit

Venue

Phyllis Kanki

Mary Woodard Lasker Professor of Health Sciences

Harvard University

Affiliations

Harvard T.h. Chan School of Public Health

Department of Immunology and Infectious Diseases

Phyllis Kanki is currently serving as an Immunology And Infectious Diseases Mary Woodard Lasker Professor of Health Sciences at Harvard University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Phyllis Kanki

Harvard University

Mary Woodard Lasker Professor of Health Sciences

You can click a keyword to filter the displayed items

hiv virology public health infectious diseases global health immunology medical virology clinical microbiology clinical epidemiology respiratory medicine virus epidemiology veterinary medicine virus-host interactions infection control emerging infectious diseases virus research viral genetics human retrovirus virus transmission viral pathogenesis disease transmission hematology general virology clinical infectious disease antiviral therapy clinical immunology clinical research international health immune responses medicinal research tropical medicine west africa viral evolution medical microbiology andrology clinical evidence mammalian biology disease outbreaks treatment and prevention antiretroviral therapy reproductive health arbovirus viral replication clinical infection human immunodeficiency virus hiv-infected patients antiviral research venereology laboratory medicine viral diagnostics avian biology reproductive medicine animal virus vaccine research connected health infectious disease modelling cohort studies avian medicine molecular epidemiology health protection antiviral responses molecular virology maternal-fetal medicine child health viral load north central nigeria risk factors systematic review natural protection bacterial vaginosis african green monkeys rapid antigen testing first-line antiretroviral therapy active antiretroviral therapy oyo state longitudinal evaluation epidemiology sars-cov-2 infectious diseases (medical specialty)

Notable Scholarly Works

Notable Federal Grants

Collaborators

Antiretroviral Therapy Retention, Adherence, and Clinical Outcomes Among Postpartum Women With Hiv in Nigeria. PLoS ONE (2024)

Clara M. YoungCharlotte A. ChangAtiene S. SagayGodwin ImadeOlabanjo O. OgunsolaProsper OkonkwoPhyllis J. Kanki

public healthhealth carevirologywomen's healthpostpartum womenhivrespiratory medicineglobal healthantiviral therapymedicineclinical outcomesmaternal healthantiretroviral therapy retention

Pretreatment and Acquired Drug Resistance in Hiv-1 Infected Children in Jos, Nigeria. Open Forum Infectious Diseases (2024)

Augustine O EbonyiJonathan OkpokwuHolly RawizzaPhilippe ChebuBeth ChaplinDonald HamelStephen OgucheOche O AgbajiAtiene S SagayPhyllis J KankiGodwin E Imade

pediatricspublic healthchild healthinfectious diseasesdisease transmissiondisease outbreakstreatment and preventionhivrespiratory medicineclinical epidemiologydrug resistanceemerging infectious diseasesveterinary medicineinfection control

Sars-Cov-2 Live Virus Culture and Sample Freeze-Thaw Stability. Diagnostic Microbiology and Infectious Disease (2024)

Phyllis J. KankiDonald J. HamelStefan RiedelSanjucta DuttaAnnie ChengCharlotte A. ChangRamy ArnaoutJames E. Kirby

clinical microbiologydiagnostic virologyepidemiologymedical microbiologyinfectious diseasesvirologysample freeze-thaw stabilitymicrobiologysars-cov-2diagnostic microbiologyviral diagnostics

West African Pre-Pandemic Cross-Reactive Antibody and Cellular Responses Against Sars-Cov-2. medRxiv (2024)

Bobby Brooke HerreraBeth ChaplinSouleymane MBoupAdam AbdullahiMichelle HeSydney M. FisherSulaimon AkanmuCharlotte A ChangDonald J HamelRavindra K. GuptaPhyllis J Kanki

vaccinesimmunologyarbovirusadaptive immune systemcovid-19clinical immunologyclinical microbiologyvaccinationhost responsecellular responsesgeneral virologyvirologyglobal healthlaboratory medicinevirus researchsars-cov-2viral persistencemedicinemedical virology

High Sars-Cov-2 Seroprevalence in Lagos, Nigeria With Robust Antibody and Cellular Immune Responses. Journal of Clinical Virology Plus (2023)

Sulaimon AkanmuBobby Brooke HerreraBeth ChaplinSade OgunsolaAkin OsibogunFatima OnawogaSarah John-OlabodeIorhen E. AkaseAugustina NwosuDonald J. HamelCharlotte A. ChangPhyllis J. Kanki

medical virologyclinical microbiologydiagnostic virologyepidemiologyinfectious diseasesvirologyimmunologyhost responsesars-cov-2robust antibodyclinical researchcovid-19general virologyvirus research

Hiv/Aids Global Epidemic. Infectious Diseases (2023)

Phyllis J. KankiCatherine K. Koofhethile

public healthinfectious diseasesdisease transmissionhivglobal health

The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for Covid-19. (2023)

Alexandra MorganElisa ContrerasMichie YasudaSanjucta DuttaDonald J. HamelTarini ShankarDiane BalalloStefan RiedelJames E. KirbyPhyllis J. KankiRamy Arnaout

public healthvirologyimmunologyrespiratory medicinemulti-cohort viral loadscovid-19coviral portalhealth sciencesantigen-test virtual trials

The Hiv-2 Proviral Landscape is Dominated by Defective Proviruses. AIDS (2023)

Catherine K. KoofhethileCe GaoCharlotte ChangXiaodong LianRoger ShapiroXu G. YuMathias LichterfeldPhyllis J. Kanki

virus epidemiologyviral pathogenesisinfectious diseasesvirologyvirus-host interactionsimmunologyhivglobal healthviral evolutiondefective provirusesviral genetics

Acceptability of and Preferences for Long-Acting Injectable Hiv Prep and Other Prep Modalities Among Sexual Minority Men in Nigeria, Africa. AIDS and Behavior (2022)

Adedotun OgunbajoAlexander C. TsaiPhyllis J. KankiKenneth H. Mayer

public healthinfectious diseasessexual minority menhivglobal health

Clinical Outcomes in a Randomized Controlled Trial Comparing Point-Of-Care With Standard Human Immunodeficiency Virus (Hiv) Viral Load Monitoring in Nigeria. Clinical Infectious Diseases (2022)

Charlotte ChangOche AgbajiKiren MitrukaBola OlatundeHalima SuleTitus DajelAaron ZeeMukhtar L AhmedIsah AhmedProsper OkonkwoBeth ChaplinPhyllis Kanki

public healthhealth monitoringepidemiologyclinical infectious diseaseinfectious diseasesvirologydisease transmissionvirus epidemiologyhivrespiratory medicineclinical epidemiologyhealth technologypatient monitoringveterinary medicineclinical outcomesclinical trialsviral load monitoringinfection control

1
2
3
4
5
24
10 / page

Phyllis Kanki

Mary Woodard Lasker Professor of Health Sciences

Harvard University

Affiliations

Harvard T.h. Chan School of Public Health

Department of Immunology and Infectious Diseases

Phyllis Kanki is currently serving as an Immunology And Infectious Diseases Mary Woodard Lasker Professor of Health Sciences at Harvard University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Phyllis Kanki

Harvard University

Mary Woodard Lasker Professor of Health Sciences

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Antiretroviral Therapy Retention, Adherence, and Clinical Outcomes Among Postpartum Women With Hiv in Nigeria. PLoS ONE (2024)

Clara M. YoungCharlotte A. ChangAtiene S. SagayGodwin ImadeOlabanjo O. OgunsolaProsper OkonkwoPhyllis J. Kanki

public healthhealth carevirologywomen's healthpostpartum womenhivrespiratory medicineglobal healthantiviral therapymedicineclinical outcomesmaternal healthantiretroviral therapy retention

Pretreatment and Acquired Drug Resistance in Hiv-1 Infected Children in Jos, Nigeria. Open Forum Infectious Diseases (2024)

Augustine O EbonyiJonathan OkpokwuHolly RawizzaPhilippe ChebuBeth ChaplinDonald HamelStephen OgucheOche O AgbajiAtiene S SagayPhyllis J KankiGodwin E Imade

Sars-Cov-2 Live Virus Culture and Sample Freeze-Thaw Stability. Diagnostic Microbiology and Infectious Disease (2024)

Phyllis J. KankiDonald J. HamelStefan RiedelSanjucta DuttaAnnie ChengCharlotte A. ChangRamy ArnaoutJames E. Kirby

clinical microbiologydiagnostic virologyepidemiologymedical microbiologyinfectious diseasesvirologysample freeze-thaw stabilitymicrobiologysars-cov-2diagnostic microbiologyviral diagnostics

West African Pre-Pandemic Cross-Reactive Antibody and Cellular Responses Against Sars-Cov-2. medRxiv (2024)

Bobby Brooke HerreraBeth ChaplinSouleymane MBoupAdam AbdullahiMichelle HeSydney M. FisherSulaimon AkanmuCharlotte A ChangDonald J HamelRavindra K. GuptaPhyllis J Kanki

High Sars-Cov-2 Seroprevalence in Lagos, Nigeria With Robust Antibody and Cellular Immune Responses. Journal of Clinical Virology Plus (2023)

Sulaimon AkanmuBobby Brooke HerreraBeth ChaplinSade OgunsolaAkin OsibogunFatima OnawogaSarah John-OlabodeIorhen E. AkaseAugustina NwosuDonald J. HamelCharlotte A. ChangPhyllis J. Kanki

medical virologyclinical microbiologydiagnostic virologyepidemiologyinfectious diseasesvirologyimmunologyhost responsesars-cov-2robust antibodyclinical researchcovid-19general virologyvirus research

Hiv/Aids Global Epidemic. Infectious Diseases (2023)

Phyllis J. KankiCatherine K. Koofhethile

public healthinfectious diseasesdisease transmissionhivglobal health

The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for Covid-19. (2023)

Alexandra MorganElisa ContrerasMichie YasudaSanjucta DuttaDonald J. HamelTarini ShankarDiane BalalloStefan RiedelJames E. KirbyPhyllis J. KankiRamy Arnaout

public healthvirologyimmunologyrespiratory medicinemulti-cohort viral loadscovid-19coviral portalhealth sciencesantigen-test virtual trials

The Hiv-2 Proviral Landscape is Dominated by Defective Proviruses. AIDS (2023)

Catherine K. KoofhethileCe GaoCharlotte ChangXiaodong LianRoger ShapiroXu G. YuMathias LichterfeldPhyllis J. Kanki

virus epidemiologyviral pathogenesisinfectious diseasesvirologyvirus-host interactionsimmunologyhivglobal healthviral evolutiondefective provirusesviral genetics

Acceptability of and Preferences for Long-Acting Injectable Hiv Prep and Other Prep Modalities Among Sexual Minority Men in Nigeria, Africa. AIDS and Behavior (2022)

Adedotun OgunbajoAlexander C. TsaiPhyllis J. KankiKenneth H. Mayer

public healthinfectious diseasessexual minority menhivglobal health

Clinical Outcomes in a Randomized Controlled Trial Comparing Point-Of-Care With Standard Human Immunodeficiency Virus (Hiv) Viral Load Monitoring in Nigeria. Clinical Infectious Diseases (2022)

Charlotte ChangOche AgbajiKiren MitrukaBola OlatundeHalima SuleTitus DajelAaron ZeeMukhtar L AhmedIsah AhmedProsper OkonkwoBeth ChaplinPhyllis Kanki

1
2
3
4
5
24
10 / page

Similar Faculty Members

Shahin Lockman

Institution

Harvard University

maternal health

obstetrics and gynaecology

David Katzenstein

Institution

Stanford University

hiv

virology

Robert Shafer

Institution

Stanford University

hiv

virology

Carey Farquhar

Institution

University of Washington

infectious diseases (medical specialty)

medicine safety

David Wohl

Institution

University of North Carolina at Chapel Hill

antiviral therapy

sars-cov-2

Michael Hudgens

Institution

University of North Carolina at Chapel Hill

infectious diseases (medical specialty)

epidemiologic method

Sten Vermund

Institution

Yale University

public health

hiv

Judith S. Currier

Institution

University of California, Los Angeles

hiv

transplant infectious disease

Charles Horsburgh

Institution

Boston University

clinical infectious disease

nontuberculous mycobacterial infections

Roger Detels

Institution

University of California, Los Angeles

hiv

public health

Similar Faculty Members

Shahin Lockman

Institution

Harvard University

maternal health

obstetrics and gynaecology

David Katzenstein

Institution

Stanford University

hiv

virology

Robert Shafer

Institution

Stanford University

hiv

virology

Carey Farquhar

Institution

University of Washington

infectious diseases (medical specialty)

medicine safety

David Wohl

Institution

University of North Carolina at Chapel Hill

antiviral therapy

sars-cov-2

Michael Hudgens

Institution

University of North Carolina at Chapel Hill

infectious diseases (medical specialty)

epidemiologic method

Sten Vermund

Institution

Yale University

public health

hiv

Judith S. Currier

Institution

University of California, Los Angeles

hiv

transplant infectious disease

Charles Horsburgh

Institution

Boston University

clinical infectious disease

nontuberculous mycobacterial infections

Roger Detels

Institution

University of California, Los Angeles

hiv

public health